Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DocGo ( (DCGO) ) has shared an update.
On December 12, 2025, DocGo Inc. announced an extension of its share repurchase program, allowing the company to buy back up to $26 million in common stock until June 30, 2026. The extension provides DocGo with flexibility in managing its capital structure, potentially benefiting shareholders by supporting stock price stability and reflecting confidence in the company’s financial health.
The most recent analyst rating on (DCGO) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on DocGo stock, see the DCGO Stock Forecast page.
Spark’s Take on DCGO Stock
According to Spark, TipRanks’ AI Analyst, DCGO is a Neutral.
DocGo’s overall stock score is primarily impacted by its financial performance challenges, including negative margins and cash flow issues. Technical analysis shows bearish trends, and valuation metrics are weak with a negative P/E ratio. The earnings call provided some positive strategic insights, but significant revenue declines and losses remain a concern.
To see Spark’s full report on DCGO stock, click here.
More about DocGo
Average Trading Volume: 1,592,709
Technical Sentiment Signal: Sell
Current Market Cap: $95.86M
Find detailed analytics on DCGO stock on TipRanks’ Stock Analysis page.